Centocor Seeks Continuing Damages Over Humira

Law360, New York (January 4, 2010, 4:36 PM EST) -- Centocor Ortho Biotech Inc. has filed a new suit against Abbott Laboratories, seeking continuing damages as Abbott appeals a $1.85 billion judgment that its arthritis treatment Humira infringes a patent held by the Johnson & Johnson unit.

The complaint — filed Dec. 28 in the U.S. District Court for the Eastern District of Texas — seeks actual and enhanced damages based on Abbott's alleged continuing willful infringement of Centocor's patent.

In June 2009, a jury in the same court awarded Centocor $1.17 billion in lost profits...
To view the full article, register now.